155 related articles for article (PubMed ID: 18593727)
1. PPAR alpha, more than PPAR delta, mediates the hepatic and skeletal muscle alterations induced by the PPAR agonist GW0742.
Faiola B; Falls JG; Peterson RA; Bordelon NR; Brodie TA; Cummings CA; Romach EH; Miller RT
Toxicol Sci; 2008 Oct; 105(2):384-94. PubMed ID: 18593727
[TBL] [Abstract][Full Text] [Related]
2. Ligand activation of peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) attenuates carbon tetrachloride hepatotoxicity by downregulating proinflammatory gene expression.
Shan W; Palkar PS; Murray IA; McDevitt EI; Kennett MJ; Kang BH; Isom HC; Perdew GH; Gonzalez FJ; Peters JM
Toxicol Sci; 2008 Oct; 105(2):418-28. PubMed ID: 18622026
[TBL] [Abstract][Full Text] [Related]
3. Comparative hepatic effects of perfluorooctanoic acid and WY 14,643 in PPAR-alpha knockout and wild-type mice.
Wolf DC; Moore T; Abbott BD; Rosen MB; Das KP; Zehr RD; Lindstrom AB; Strynar MJ; Lau C
Toxicol Pathol; 2008 Jun; 36(4):632-9. PubMed ID: 18467680
[TBL] [Abstract][Full Text] [Related]
4. Development of PPAR-agonist GW0742 as antidiabetic drug: study in animals.
Niu HS; Ku PM; Niu CS; Cheng JT; Lee KS
Drug Des Devel Ther; 2015; 9():5625-32. PubMed ID: 26508837
[TBL] [Abstract][Full Text] [Related]
5. High sugar intake and development of skeletal muscle insulin resistance and inflammation in mice: a protective role for PPAR- δ agonism.
Benetti E; Mastrocola R; Rogazzo M; Chiazza F; Aragno M; Fantozzi R; Collino M; Minetto MA
Mediators Inflamm; 2013; 2013():509502. PubMed ID: 23861559
[TBL] [Abstract][Full Text] [Related]
6. The PPARα agonists fenofibrate and CP-778875 cause increased β-oxidation, leading to oxidative injury in skeletal and cardiac muscle in the rat.
Pettersen JC; Pruimboom-Brees I; Francone OL; Amacher DE; Boldt SE; Kerlin RL; Ballinger WE
Toxicol Pathol; 2012 Apr; 40(3):435-47. PubMed ID: 22301950
[TBL] [Abstract][Full Text] [Related]
7. Peroxisome proliferator-activated receptor δ agonist attenuates hepatic steatosis by anti-inflammatory mechanism.
Lee MY; Choi R; Kim HM; Cho EJ; Kim BH; Choi YS; Naowaboot J; Lee EY; Yang YC; Shin JY; Shin YG; Chung CH
Exp Mol Med; 2012 Oct; 44(10):578-85. PubMed ID: 22824914
[TBL] [Abstract][Full Text] [Related]
8. Effect of PPAR-β/δ agonist GW0742 treatment in the acute phase response and blood-brain barrier permeability following brain injury.
Chehaibi K; le Maire L; Bradoni S; Escola JC; Blanco-Vaca F; Slimane MN
Transl Res; 2017 Apr; 182():27-48. PubMed ID: 27818230
[TBL] [Abstract][Full Text] [Related]
9. Protective role of peroxisome proliferator-activated receptor-β/δ in septic shock.
Kapoor A; Shintani Y; Collino M; Osuchowski MF; Busch D; Patel NS; Sepodes B; Castiglia S; Fantozzi R; Bishop-Bailey D; Mota-Filipe H; Yaqoob MM; Suzuki K; Bahrami S; Desvergne B; Mitchell JA; Thiemermann C
Am J Respir Crit Care Med; 2010 Dec; 182(12):1506-15. PubMed ID: 20693380
[TBL] [Abstract][Full Text] [Related]
10. Fatty acid homeostasis and induction of lipid regulatory genes in skeletal muscles of peroxisome proliferator-activated receptor (PPAR) alpha knock-out mice. Evidence for compensatory regulation by PPAR delta.
Muoio DM; MacLean PS; Lang DB; Li S; Houmard JA; Way JM; Winegar DA; Corton JC; Dohm GL; Kraus WE
J Biol Chem; 2002 Jul; 277(29):26089-97. PubMed ID: 12118038
[TBL] [Abstract][Full Text] [Related]
11. PPAR-β/δ activation promotes phospholipid transfer protein expression.
Chehaibi K; Cedó L; Metso J; Palomer X; Santos D; Quesada H; Naceur Slimane M; Wahli W; Julve J; Vázquez-Carrera M; Jauhiainen M; Blanco-Vaca F; Escolà-Gil JC
Biochem Pharmacol; 2015 Mar; 94(2):101-8. PubMed ID: 25662586
[TBL] [Abstract][Full Text] [Related]
12. Toxic effects of fumonisin in mouse liver are independent of the peroxisome proliferator-activated receptor alpha.
Voss KA; Liu J; Anderson SP; Dunn C; Miller JD; Owen JR; Riley RT; Bacon CW; Corton JC
Toxicol Sci; 2006 Jan; 89(1):108-19. PubMed ID: 16221962
[TBL] [Abstract][Full Text] [Related]
13. Evidence for peroxisome proliferator-activated receptor (PPAR)alpha-independent peroxisome proliferation: effects of PPARgamma/delta-specific agonists in PPARalpha-null mice.
DeLuca JG; Doebber TW; Kelly LJ; Kemp RK; Molon-Noblot S; Sahoo SP; Ventre J; Wu MS; Peters JM; Gonzalez FJ; Moller DE
Mol Pharmacol; 2000 Sep; 58(3):470-6. PubMed ID: 10953038
[TBL] [Abstract][Full Text] [Related]
14. Mouse carnitine-acylcarnitine translocase (CACT) is transcriptionally regulated by PPARalpha and PPARdelta in liver cells.
Gutgesell A; Wen G; König B; Koch A; Spielmann J; Stangl GI; Eder K; Ringseis R
Biochim Biophys Acta; 2009 Oct; 1790(10):1206-16. PubMed ID: 19577614
[TBL] [Abstract][Full Text] [Related]
15. WY-14,643 induced cell proliferation and oxidative stress in mouse liver are independent of NADPH oxidase.
Woods CG; Burns AM; Bradford BU; Ross PK; Kosyk O; Swenberg JA; Cunningham ML; Rusyn I
Toxicol Sci; 2007 Aug; 98(2):366-74. PubMed ID: 17483499
[TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferator-activated receptor β/δ agonist GW0742 ameliorates cerulein- and taurocholate-induced acute pancreatitis in mice.
Paterniti I; Mazzon E; Riccardi L; Galuppo M; Impellizzeri D; Esposito E; Bramanti P; Cappellani A; Cuzzocrea S
Surgery; 2012 Jul; 152(1):90-106. PubMed ID: 22521259
[TBL] [Abstract][Full Text] [Related]
17. Protective role of peroxisome proliferator-activated receptor-β/δ against pulmonary oxygen toxicity mediated through changes in NOS expression levels.
Bao XC; Fang YQ; You P; Zhang S; Ma J
Exp Lung Res; 2014 Apr; 40(3):105-16. PubMed ID: 24624894
[TBL] [Abstract][Full Text] [Related]
18. Activation of peroxisome proliferator-activated receptor-beta/delta attenuates myocardial ischemia/reperfusion injury in the rat.
Kapoor A; Collino M; Castiglia S; Fantozzi R; Thiemermann C
Shock; 2010 Aug; 34(2):117-24. PubMed ID: 19997057
[TBL] [Abstract][Full Text] [Related]
19. Dual peroxisome proliferator-activated receptor α/δ agonist GFT505 improves hepatic and peripheral insulin sensitivity in abdominally obese subjects.
Cariou B; Hanf R; Lambert-Porcheron S; Zaïr Y; Sauvinet V; Noël B; Flet L; Vidal H; Staels B; Laville M
Diabetes Care; 2013 Oct; 36(10):2923-30. PubMed ID: 23715754
[TBL] [Abstract][Full Text] [Related]
20. Complementary Immunometabolic Effects of Exercise and PPARβ/δ Agonist in the Context of Diet-Induced Weight Loss in Obese Female Mice.
Le Garf S; Murdaca J; Mothe-Satney I; Sibille B; Le Menn G; Chinetti G; Neels JG; Rousseau AS
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31635041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
